Yaqrit strengthens board and senior management ahead of multi-prong clinical push in advanced liver disease
Ex-Takeda VP Tauhid Ali, Ph.D., with broad leadership and drug development experience becomes Board DirectorSeasoned regulatory strategist Darren ...
Hosted on MSN2d
Bankruptcy twist in J&J's attempt to settle cancer claims
Johnson & Johnson (J&J) is facing a pivotal legal challenge as it seeks approval for a $10bn settlement plan to resolve allegations that its talc-based baby powder products caused ovarian cancer.The ...
J&J begins crucial battle over $10 billion baby powder settlement
Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby ...
Zacks.com on MSN4d
J&J Stock Up More Than 6% in a Month: Time to Buy, Sell or Hold?
J&J JNJ stock has risen more than 6% in the past month. The reason behind the increase was a strong-than-expected ...
J&J resumes US rollout of Varipulse heart device after investigation
Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...